Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Long-Term Deferred Tax (2024)

BioAtla (BCAB) has disclosed Long-Term Deferred Tax for 1 consecutive years, with $183000.0 as the latest value for Q4 2024.

  • For Q4 2024, Long-Term Deferred Tax changed N/A year-over-year to $183000.0; the TTM value through Dec 2024 reached $183000.0, changed N/A, while the annual FY2024 figure was $183000.0, N/A changed from the prior year.
  • Long-Term Deferred Tax hit $183000.0 in Q4 2024 for BioAtla.
  • Across five years, Long-Term Deferred Tax topped out at $183000.0 in Q4 2024 and bottomed at $183000.0 in Q4 2024.